These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32563288)
41. Mind matters: placebo enhances reward learning in Parkinson's disease. Schmidt L; Braun EK; Wager TD; Shohamy D Nat Neurosci; 2014 Dec; 17(12):1793-7. PubMed ID: 25326691 [TBL] [Abstract][Full Text] [Related]
42. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease. Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420 [TBL] [Abstract][Full Text] [Related]
43. The temporal precision of reward prediction in dopamine neurons. Fiorillo CD; Newsome WT; Schultz W Nat Neurosci; 2008 Aug; 11(8):966-73. PubMed ID: 18660807 [TBL] [Abstract][Full Text] [Related]
44. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. Schweinhardt P; Seminowicz DA; Jaeger E; Duncan GH; Bushnell MC J Neurosci; 2009 Apr; 29(15):4882-7. PubMed ID: 19369556 [TBL] [Abstract][Full Text] [Related]
45. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. da Silva Alves F; Bakker G; Schmitz N; Abeling N; Hasler G; van der Meer J; Nederveen A; de Haan L; Linszen D; van Amelsvoort T Eur Neuropsychopharmacol; 2013 Nov; 23(11):1577-86. PubMed ID: 23978392 [TBL] [Abstract][Full Text] [Related]
46. The placebo effect in Parkinson's disease. de la Fuente-Fernández R; Stoessl AJ Trends Neurosci; 2002 Jun; 25(6):302-6. PubMed ID: 12086748 [TBL] [Abstract][Full Text] [Related]
57. The placebo response: neurobiological and clinical issues of neurological relevance. Pollo A; Benedetti F Prog Brain Res; 2009; 175():283-94. PubMed ID: 19660663 [TBL] [Abstract][Full Text] [Related]
58. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease. van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226 [TBL] [Abstract][Full Text] [Related]
59. Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature. Zanjani A; Zakzanis KK; Daskalakis ZJ; Chen R Mov Disord; 2015 May; 30(6):750-8. PubMed ID: 25786995 [TBL] [Abstract][Full Text] [Related]
60. New insights into the placebo and nocebo responses. Enck P; Benedetti F; Schedlowski M Neuron; 2008 Jul; 59(2):195-206. PubMed ID: 18667148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]